A Case of Metastatic Adamantinoma That Responded Well to Sunitinib
Adamantinoma is a rare low-grade malignant bone tumor of epithelial origin. Metastatic adamantinoma has been reported to be resistant to chemotherapy. We report a case of metastatic adamantinoma to the lung, 10 years after the initial diagnosis of tibial mass. The patient received radiation therapy...
Saved in:
Main Authors: | Andrew D. Liman, Agnes K. Liman, Jenna Shields, Becky Englert, Rashmikant Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2016/5982313 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the anti-metastatic potential of sunitinib and novel analogs in colorectal cancer: insights into HIF-1α mediated metastasis
by: Fatemeh B. Rassouli, et al.
Published: (2025-02-01) -
Objective Clinical and Radiological Response under Sunitinib in a Case of Thigh Hidradenocarcinoma
by: S. Korbi, et al.
Published: (2020-01-01) -
Adamantinoma-Like Ewing’s Family Tumor of the Sino Nasal Region: A Case Report and a Brief Review of Literature
by: Pushpa Mahadevan, et al.
Published: (2019-01-01) -
Tibia Adamantinoma Resection and Reconstruction with a Custom-Made Total Tibia Endoprosthesis: A Case Report with 8-Year Follow-Up
by: Gilber Kask, et al.
Published: (2018-01-01) -
Fibula-Assisted Segment Transport (FAST) for Defect Reconstruction after Resection of Tibial Adamantinoma: Report of Two Treatments
by: A. Rachbauer, et al.
Published: (2021-01-01)